Position in IDYA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,579,888
+$907,359 QoQ
Shares Held
230,209
-0.0% QoQ
Ownership
0.239%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 286 holders
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,184,405,765 across 177 Biotechnology names. IDYA ranks #78 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in IDYA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,579,888 | 230,209 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,672,529 | 230,268 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,304,024 | 240,209 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $6,405,913 | 235,425 | Shares | Defined | 2025-11-13 | |
| 2024-06-30 | $1,113,864 | 31,725 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,133,155 | 25,824 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $969,090 | 27,237 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $700,858 | 25,977 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $523,109 | 22,260 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||